PR
NASDAQ · PRPO
Precipio, Inc.
Healthcare · Medical - Diagnostics & Research
$26.66
Down-$0.22 (-0.83%)
Updated Sep 17, 2026, 11:57 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 37.66M
- P/E ratio
- -31.99
- Dividend yield
- 0.00%
- 52-week range
- $16.00 – $33.63
- Volume
- 39.09K
- Avg. volume
- 15.04K
Price performance
PRPO price history
1M range · 20 trading sessions · Daily adjusted prices
PRPO closed at $26.66 after 20 trading sessions, down 4.27% for the selected period.
- Last close
- $26.66
- Period change
- -4.27%
- Period low
- $25.60
- Period high
- $31.12
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $27.175 | $27.19 | $25.72 | $26.66 | 39.09K |
| Sep 15, 2026 | $27.23 | $27.71 | $26.53 | $27.16 | 111K |
| Sep 14, 2026 | $27.20 | $27.72 | $26.90 | $27.23 | 62.64K |
| Sep 11, 2026 | $27.03 | $28.00 | $26.25 | $27.32 | 89.11K |
| Sep 10, 2026 | $25.21 | $27.405 | $25.21 | $26.91 | 236.33K |
| Sep 9, 2026 | $27.10 | $27.10 | $25.495 | $25.60 | 132.82K |
| Sep 8, 2026 | $26.87 | $27.80 | $25.63 | $27.25 | 304.06K |
| Sep 4, 2026 | $26.11 | $27.90 | $24.48 | $27.40 | 114.54K |
| Sep 3, 2026 | $27.67 | $27.96 | $25.91 | $26.12 | 423.79K |
| Sep 2, 2026 | $27.93 | $28.16 | $26.77 | $27.50 | 237.05K |
| Sep 1, 2026 | $27.41 | $28.80 | $27.06 | $27.765 | 211.24K |
| Aug 31, 2026 | $28.85 | $29.905 | $27.27 | $27.69 | 94.5K |
| Aug 28, 2026 | $29.38 | $30.55 | $28.60 | $28.85 | 205.15K |
| Aug 27, 2026 | $30.30 | $30.39 | $28.85 | $29.29 | 36.69K |
| Aug 26, 2026 | $30.43 | $32.57 | $29.57 | $30.405 | 91.03K |
| Aug 25, 2026 | $30.96 | $31.82 | $30.07 | $30.85 | 258.27K |
| Aug 24, 2026 | $30.45 | $31.41 | $29.54 | $31.12 | 29.69K |
| Aug 21, 2026 | $29.48 | $30.45 | $27.0001 | $30.45 | 69.65K |
| Aug 20, 2026 | $27.76 | $29.60 | $27.10 | $29.43 | 366.64K |
| Aug 19, 2026 | $25.01 | $27.85 | $24.63 | $27.85 | 92.81K |
Latest PRPO news
The latest Smart Investors Daily articles mentioning PRPO.
Stock researchResearch & News · Competitors
Loading stock research…
